In Compliance with the disclosure under Regulation 31(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulation, 2011, as amended, Camlin Fine Sciences has informed that it attached disclosure (Annexure-I and Annexure-II) in the prescribed format in relation to pledge of additional 10,00,000 Equity Shares of the Company.
The above information is a part of company’s filings submitted to BSE.